NCT06943495
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06943495
Title Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2) (PRODIGY-2)
Acronym PRODIGY-2
Recruitment Not yet recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Jean-Mathieu Beauregard
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.